c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion

Neuroscience Letters

Volumn 284, Issue 3, 2000, Pages 195-199

  Hayashi, Takeshi ^a   Sakai, Ken Ichi ^a   Sasaki, Chihoko ^a   Zhang, Wen Ri ^a   Warita, Hitoshi ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

C Jun N terminal kinase; C Jun N terminal kinase interacting protein; Immunohistochemistry; Ischemia; Rat

Indexed keywords

INHIBITOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOREACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; TRANSIENT ISCHEMIC ATTACK;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL NUCLEUS; CEREBRAL ARTERIES; CEREBRAL CORTEX; CYTOPLASM; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PHOSPHORYLATION; RATS; RATS, WISTAR; REPERFUSION; TIME FACTORS;

EID: 0034724978     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01024-7     Document Type: Article

References (18)

1. Asahi M., Hoshimaru M., Uemura Y., Tokime T., Kojima M., Ohtsuka T., Matsuura N., Aoki T., Shibahara K., Kikuchi H. Expression of interleukin-1β converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J. Cereb. Blood Flow. Metab. 17:1997;11-18.
2. Becker A.J., Gillardon F., Blümcke I., Langendörfer D., Beck H., Wiestler O.D. Differential regulation of apoptosis-related genes in resistant and vulnerable subfields of the rat epileptic hippocampus. Mol. Brain Res. 67:1999;172-176.
3. Brecht S., Mielke K., Yu M.H., Herdegen T. The activation of the JNK/c-Jun axis and expression of the Fas-ligand following focal ischemia are prevented by the immunosuppressant FK506. Krieglestein J. Pharmacology of Cerebral Ischemia. 1998;151-159 Medpharm Scientific Publishers, Stuttgart.
4. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow. Metab. 16:1996;186-194.
5. Chen S.C., Soares H.D., Morgan J.I. Novel molecular correlates of neuronal death and regeneration. Siesjö B.K., Wieloch T. Cellular and Molecular Mechanisms of Ischemic Brain Damage. Advances in Neurology. Vol. 71:1996;433-450 Lippincott-Raven, Philadelphia.
6. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277:1997;693-696.
7. Eilers A., Whitfield J., Babij C., Rubin L.L., Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18:1998;1713-1724.
8. Estus S., Zaks W.J., Freeman R.S., Gruda M., Braro R., Johnson E.M. Jr. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
9. Gillardon F., Spranger M., Tiesler C., Hossmann K.A. Expression of cell death-associated phospho-c-jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia. Mol. Brain Res. 73:1999;138-143.
10. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
11. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., Rubin L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
12. Hayashi T., Abe K., Suzuki H., Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke. 28:1997;2039-2044.
13. Hayashi T., Warita H., Abe K., Itoyama Y. Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci. Lett. 265:1999;37-40.
14. Herdegen T., Claret F.X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18:1998;5124-5135.
15. Kim I.J., Lee K.W., Park B.Y., Lee J.K., Park J., Choi I.Y., Eom S.J., Chang T.S., Kim M.J., Yeom Y.I., Chang S.K., Lee Y.D., Choi E.J., Han P.L. Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain. J. Neurochem. 72:1999;1335-1343.
16. Li Y., Chopp M., Powers C., Jiang N. Immunoreactivity of cyclin D1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 17:1997;846-856.
17. Linnik M.D., Zobrist R.H., Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2009.
18. MacManus J.P., Linnik M.D. Gene expression induced by cerebral ischemia: an apoptotic perspective. J. Cereb. Blood Flow Metab. 17:1997;815-832.